ImageneBio Income Statement (2020-2024) | IMA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Revenue & cost
Revenue 3.23M3.07M2.83M0.07M3.47M3.55M3.75M20.22M3.38M0.38M6.40M5.45M5.31M2.00M1.19M0.66M3.50M
Operating items
Research & Development 7.89M6.33M7.22M23.40M10.02M11.37M13.38M12.34M14.34M15.49M18.85M15.64M15.55M15.17M14.65M14.27M9.64M9.83M3.88M2.52M
Wages, Salaries and Other 0.57M
Selling, General & Administrative 2.51M1.80M1.84M2.72M3.17M4.86M4.89M5.09M6.00M5.84M5.43M4.92M5.28M5.32M6.03M8.29M6.00M5.31M1.65M17.67M
Restructuring Costs 2.60M0.68M0.41M2.08M
Other Operating Expenses -0.02M-0.41M2.34M
Operating Expenses 10.40M8.13M9.06M26.12M13.19M16.24M18.27M17.43M20.35M21.33M24.28M20.56M20.83M20.49M20.69M22.57M18.23M15.82M5.54M24.61M
Operating Income -7.18M-5.06M-6.23M-26.05M-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M
EBIT -7.18M-5.06M-6.23M-26.05M-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M
Non-operating items
Interest & Investment Income 0.01M0.01M0.01M0.17M0.46M0.55M1.01M1.30M1.38M2.16M2.27M2.11M1.92M0.05M7.03M
Other Non Operating Income 0.23M0.02M0.01M0.00M0.00M0.01M0.01M0.01M-0.05M0.46M0.54M1.02M0.57M-0.01M-0.00M-0.01M-0.01M0.23M-1.19M3.76M
Non Operating Income 0.23M0.02M0.01M0.00M0.00M0.01M0.01M0.01M0.12M0.46M0.54M1.02M1.30M1.38M2.16M2.26M2.11M2.15M-1.19M11.13M
Net income details
EBT -7.18M-5.06M-6.23M-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.12M-13.67M-3.18M-17.33M
Tax Provisions 0.03M0.06M0.15M
Profit After Tax -6.95M-5.04M-6.22M-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.49M-17.34M-14.10M-14.22M-17.11M-17.34M-19.49M-16.15M-13.73M-3.18M-17.48M
Income from Continuing Operations -7.18M-5.06M-6.23M-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M
Consolidated Net Income -7.18M-5.06M-6.23M-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M
Income towards Parent Company -7.18M-5.06M-6.23M-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M
Preferred Dividend Payments 3.00M
Net Income towards Common Stockholders -7.18M-5.06M-6.23M-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-6.18M-17.48M
Additional items
EPS (Basic) -2.62-1.89-2.34-9.15-2.52-0.35-0.400.10-0.47-0.57-0.48-0.39-0.39-0.44-0.40-0.40-0.33-0.28-2.5818.12
EPS (Weighted Average and Diluted) -0.35-0.400.10-0.47-0.57-0.48-0.39-0.39-0.44-0.40-0.40-0.33-0.28-2.5818.12
Shares Outstanding (Weighted Average) 2.66M2.66M2.66M2.77M3.85M35.85M35.86M27.98M36.08M36.16M36.26M36.19M36.26M39.29M43.44M41.74M48.26M48.26M1.40M
Shares Outstanding (Diluted Average) 35.85M35.86M27.98M36.08M36.16M36.26M36.19M36.26M39.29M43.44M41.74M48.26M48.26M1.40M
EBITDA -7.18M-5.06M-6.23M-26.05M-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M
Interest Expenses 0.05M0.05M0.01M-0.00M0.01M0.00M0.01M
Shares Outstanding 2.66M2.66M2.66M3.10M35.85M35.86M35.88M35.98M36.11M36.25M36.26M36.26M36.26M42.30M44.10M0.99M0.99M0.99M1.41M
Tax Rate -0.17-0.45-0.88